National Stroke Association’s Faces of Stroke℠ public awareness campaign aims to change the public perceptions of stroke through education and personal stories of those impacted by the fifth leading cause of death.
These stories bring special attention to specific health conditions associated closely with stroke, featuring an issue or concern that stroke survivors and people at risk for stroke may deal with daily.
Display of the Faces of Stroke stories does not imply National Stroke Association’s endorsement of any product, treatment, service or entity. National Stroke Association strongly recommends that people ask a healthcare professional about diagnosis and treatment questions before using any product, treatment or service. The views expressed through the stories reflect those of the authors and do not reflect the opinion of National Stroke Association.
Faces of Stroke campaign is supported by funding provided by Boehringer Ingelheim Pharmaceuticals, Inc., Allergan, Inc., Medtronic, Inc., Avanir Pharmaceuticals, Inc., Acorda Therapeutics, Inc., and Genentech Inc.